Qiagen NV Target Price

See Qiagen NV's analyst price targets ($43) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$43.69

Average Target Price

$43.01

1.5% downside

7 analysts in the last 4 months

High: $48 | Low: $38.6

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-09	UBSDoug Schenkel	$47	7.6% upside
2026-08-07	Stifel NicolausDaniel Arias	$40	8.4% downside
2026-08-07	Barclays	$40	8.4% downside
2026-08-06	Jefferies	$48	9.9% upside
2026-07-14	Berenberg BankHarry Gillis	$45.5	4.1% upside
2026-06-25	Kepler Capital	$38.6	11.7% downside
2026-06-23	Morgan Stanley	$42	3.9% downside
2026-05-18	Stifel Nicolaus	$36	17.6% downside
2026-04-30	Deutsche BankJan Koch	$43	1.6% downside
2026-04-29	BarclaysLuke Sergott	$38	13% downside
2026-04-29	Robert W. Baird	$43	1.6% downside
2026-04-14	Barclays	$44	0.7% upside
2026-02-09	UBS	$52	19% upside
2026-02-06	Robert W. BairdCathy Ramsey Schulte	$53	21.3% upside
2026-02-06	Stifel Nicolaus	$50	14.4% upside
2026-02-06	Barclays	$58	32.8% upside
2026-02-05	Jefferies	$59	35% upside
2026-01-22	Deutsche BankJan Koch	$54	23.6% upside
2025-12-15	Barclays	$57.89	32.5% upside
2025-10-02	BarclaysCatherine Ramsey Schulte	$55.79	27.7% upside
2024-10-17	HSBCShubhangi Gupt	$51.58	18.1% upside
2024-06-27	Wolfe ResearchDoug Schenkel	$52.63	20.5% upside
2024-06-18	UBSJohn Sourbeer	$48.42	10.8% upside
2021-11-04	Cowen & Co.Daniel Brennan	$61.05	39.7% upside
2021-07-15	Bank of America SecuritiesDerik De Bruin	$54.74	25.3% upside
2021-07-14	CitigroupPatrick B Donnelly	$61.05	39.7% upside
2021-07-13	Warburg ResearchUlrich Huwald	$52.89	21.1% upside

Qiagen NV (QGEN) FAQ

As of the most recent data, QGEN shows a target price of $43. Scroll down for historical charts and peer comparison views.

If Qiagen NV moved to the average analyst target of $43, shares would be roughly 1.5% lower than $43.69. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Qiagen NV's earnings trajectory.

Besides this target price page, Stockcircle has Qiagen NV's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $43) with ownership activity and broader fundamentals.

Qiagen NV's target price is $43; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.